Determination of acyclovir in horse plasma and body fluids by high-performance liquid chromatography combined with fluorescence detection and heated electrospray ionization tandem mass spectrometry

Biomedical Chromatography

Volumn 23, Issue 2, 2009, Pages 132-140

  Maes, An ^a   Garre B ^a   Desmet, N ^a   van der Meulen, K ^a   Nauwynck, H ^a   De Backer, P ^a   Croubels, S ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Acyclovir; Body fluids (nasal fluid, PBMC, cerebrospinal fluid); Ganciclovir; HPLC fluorescence; LC MS MS; Plasma; Quantification; Validation

Indexed keywords

ELECTROSPRAY IONIZATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; VIRUSES;

ACYCLOVIR; BODY FLUID (NASAL FLUID, PBMC, CEREBROSPINAL FLUID); GANCICLOVIR; HEATED ELECTROSPRAY IONIZATION; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC-FLUORESCENCE; LC-MS-MS; LC.MS/MS; QUANTIFICATION; VALIDATION;

CEREBROSPINAL FLUID;

ACICLOVIR; GANCICLOVIR;

ARTICLE; CONCENTRATION PROCESS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; LIQUID LIQUID EXTRACTION; NONHUMAN; NOSE MUCUS; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

EQUIDAE;

EID: 65349094094     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1093     Document Type: Article

References (32)

1. Anonymous. Commission Decision (2002/657/EC) of 17 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communion 2002; L221: 8.
2. Anonymous. 2005. Notice to applicants. Veterinary medical products. Establishment of maximum residue limits (MRLs) for residues of veterinary products in foodstuff of animal origin. The Rules Governing Medical Products in the European Union, Vol. 8, October 2005.
3. Bahrami G, Mirzaeeil S and Kiani A. Determination of acyclovir in human serum by high-performance liquid chromatography using liquid-liquid extraction and its application in pharmacokinetic studies. Journal of Chromatography B 2005; 816: 327-331.
4. Bangaru RA, Bansal YK, Rao ARM and Gandhi TP. Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies. Journal of Chromatography B 2000; 739: 231-237.
5. Basavaiah K, Prameela HC and Chandrashekar U. Simple high-performance liquid chromatographic method for the determination of acyclovir in pharmaceuticals. Il Farmaco 2003; 58: 1301-1306.
6. Blum MR, Liao SH and de Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. American Journal of Medicine 1982; 73(1A): 186-192.
7. Boulieu R, Gallanta C and Silbersteina N. Determination of acyclovir in human plasma by high-performance liquid chromatography. Journal of Chromatography B 1997; 693: 233-236.
8. Brown SD, White CA, Chu CK and Bartlett MG. Determination of acyclovir in maternal plasma, amniotic fluid, fetal and placental tissues by highperformance liquid chromatography. Journal of Chromatography B 2002; 772: 327-334.
9. Brown SD, White CA and Bartlett MG. Hydrophilic interaction liquid chromatography/electrospray mass spectrometry determination of acyclovir in pregnant rat plasma and tissues. Rapid Communications in Mass Spectrometry 2002; 16: 1871-1876.
10. De Clercq E. Antiviral drugs in current clinical use. Journal of Clinical Virology 2004; 30: 115-133.
11. de Jalón EG, Campanero MA, Ygartua P and Santoyo S. HPLC determination of acyclovir in skin layers and percutaneous penetration samples. Journal of Liquid Chromatography and Related Technologies 2002; 25: 3187-3197.
12. Fernández M, Sepúlveda J, Aránguiz T and von Plessing C. Technique validation by liquid chromatography for the determination of acyclovir in plasma. Journal of Chromatography B 2003; 791: 357-363.
13. Garré B, Shebany K, Gryspeerdt A, Baert K, van der Meulen K, Nauwynck H, Deprez P, De Backer P and Croubels S. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in Healthy adult horses. Antimicrobial Agents and Chemotherapy 2007; 51(12): 4308-4314.
14. Heitzman RJ. Veterinary Drug Residues Report. Eur 15127-EN, Commission of the EC, Brussels-Luxembourg, 1994.
15. Jankowski A, Jankowska AL and Lamparczyk H. Determination and pharmacokinetics of acyclovir after ingestion of suspension form. Journal of Pharmaceutical and Biomedical Analysis 1998; 18: 249-254.
16. Jin L, Wei G, Lu WY, Xu LJ and Pan J. Quantitative determination of acyclovir in aqueous humor by LC-MS. Chromatographia 2006; 63: 239-242.
17. Kishino S, Takekuma Y, Sugawara M, Shimamura T, Furukawa H, Todo S and Miyazaki K. Liquid chromatographic method for the determination of ganciclovir and/or acyclovir in human plasma using pulsed amperometric detection. Journal of Chromatography B 2002; 780: 289-894.
18. Knecht J and Stork G. Percentage and logarithmic procedures for calculation of calibration curves. Fresenius Zeitschrift für Analytischen Chemie 1974; 270 (2): 97-99.
19. Lee HW, Seo JH and Lee KT. Development and validation of a highperformance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: application to a bioequivalence study. Journal of Chromatography B 2007; 852: 382-388.
20. Loregian A, Gatti R, Palù G and De Palo EF. Separation methods for acyclovir and related antiviral compounds. Journal of Chromatography B 2001; 764: 289-311.
21. Merodio M, Campanero MA, Mirshahi T, Mirshahi M and Irache JM. Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography. Journal of Chromatography A 2000; 870: 159-167.
22. Murry MJ, del Piero F, Jeffrey SC, Davis MS, Furr MO, Dubovi EJ and Mayo JA. Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. Journal of Veterinary Internal Medicine 1998; 12: 36-41.
23. Peh KK and Yuen KH. Simple high-performance liquid chromatographic method for the determination of acyclovir in human plasma using fluorescence detection. Journal of Chromatography B 1997; 693: 241-244.
24. Pham-Huy C, Stathoulopoulou F, Sandouk P, Scherrmann JM, Palombo S and Girre C. Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution. Journal of Chromatography B 1999; 732: 47-53.
25. Poirier JM, Radembino N and Jaillon P. Determination of acyclovir in plasma by solid-phase extraction and column liquid chromatography. Therapeutic Drug Monitoring 1999; 21: 129-133.
26. Stagni G, Ali ME and Weng D. Pharmacokinetics of acyclovir in rabbit skin after IV-bolus, ointment, and iontophoretic administrations. International Journal of Pharmaceutics 2004; 274: 201-211.
27. Svensson JO, Barkholt L and Säwe J. Determination of acyclovir and its metabolite 9-carboxymethoxymethylgyanine in serum and urine using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B 1997; 690: 363-366.
28. Tadepalli SM, Quinn RP and Averett DR. A. competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine. Antimicrobial Agents and Chemotherapy 1986; 29: 93-98.
29. Trottet L, Owen H, Holme P, Heylings J, Collin IP, Breen AP, Siyad MN, Nandra RS and Davis AF. Are all acyclovir cream formulations bioequivalent? International Journal of Pharmaceutics 2005; 304: 63-71.
30. Tsuchie M, Hara S, Kimura M, Fujii M, Ono N and Kai M. Determination of anti-virus drug, ganciclovir, in human serum by HPLC with precolumn fluorescence derivatization using phenylglyoxal. Analytical Sciences 2001; 17: 811-814.
31. van der Meulen K, Vercauteren G, Nauwynck H and Pensaert M. A local epidemic of equine herpesvirus 1-induced neurological disorders in Belgium. Vlaams Diergeneeskundig Tijdschrift 2002; 72: 336-372.
32. Xu HR, Li XN, Chen WL, Liu GY, Chu NN and Yu C. A sensitive assay for simultaneous determination of plasma concentrations of valaciclovir and its active metabolite ganciclovir by LC/MS/MS. Journal of Chromatography B 2007; 848: 329-334.